Veterinary Medicines

GAMALC, (166+34+50+220)MG/ML ενέσιμο διάλυμα για πρόβατα

Authorised
  • Calcium gluconate
  • Boric acid
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
  • Lactose monohydrate
Download as PDF

Product identification

Medicine name:
GAMALC, (166+34+50+220)MG/ML ενέσιμο διάλυμα για πρόβατα
Active substance:
  • Calcium gluconate
  • Boric acid
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
  • Lactose monohydrate
Target species:
  • Sheep
Route of administration:
  • Submucosal use
  • Intravenous bolus use

Product details

Active substance and strength:
  • Calcium gluconate
    166.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Boric acid
    34.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lactose monohydrate
    220.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Submucosal use
    • Sheep
      • Meat and offal, milk
        no withdrawal period
  • Intravenous bolus use
    • Sheep
      • Meat and offal, milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Hellafarm S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories (Ireland) Limited
  • Norbrook Laboratories (Ireland) Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 27485/24-11-2004/K-0155301
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."